KR101002774B1 - 생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 - Google Patents
생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 Download PDFInfo
- Publication number
- KR101002774B1 KR101002774B1 KR1020080096215A KR20080096215A KR101002774B1 KR 101002774 B1 KR101002774 B1 KR 101002774B1 KR 1020080096215 A KR1020080096215 A KR 1020080096215A KR 20080096215 A KR20080096215 A KR 20080096215A KR 101002774 B1 KR101002774 B1 KR 101002774B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- solid content
- extract
- pill
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims 2
- 239000003814 drug Substances 0.000 title description 5
- 239000000284 extract Substances 0.000 claims abstract description 39
- 239000007787 solid Substances 0.000 claims abstract description 32
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 30
- 241000411851 herbal medicine Species 0.000 claims abstract description 26
- 241000973495 Odax pullus Species 0.000 claims abstract description 25
- 241000208340 Araliaceae Species 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 23
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 23
- 210000003056 antler Anatomy 0.000 claims abstract description 23
- 235000008434 ginseng Nutrition 0.000 claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 claims abstract description 17
- 239000012141 concentrate Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 8
- 241000255789 Bombyx mori Species 0.000 claims abstract description 7
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 7
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 7
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 7
- 230000036541 health Effects 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 235000017276 Salvia Nutrition 0.000 claims abstract description 5
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 5
- 239000006187 pill Substances 0.000 claims description 18
- 244000170916 Paeonia officinalis Species 0.000 claims description 6
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 6
- 240000002045 Guettarda speciosa Species 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 239000013589 supplement Substances 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 235000014106 fortified food Nutrition 0.000 claims description 4
- 235000008216 herbs Nutrition 0.000 claims description 4
- 230000002787 reinforcement Effects 0.000 claims description 4
- 241000251511 Holothuroidea Species 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000003014 reinforcing effect Effects 0.000 claims description 3
- 241001474374 Blennius Species 0.000 claims 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 1
- 230000036299 sexual function Effects 0.000 abstract description 15
- 241000512259 Ascophyllum nodosum Species 0.000 abstract description 6
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000010977 jade Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 235000015961 tonic Nutrition 0.000 description 11
- 230000001256 tonic effect Effects 0.000 description 11
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000007103 stamina Effects 0.000 description 8
- 230000001882 diuretic effect Effects 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001850 reproductive effect Effects 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000011045 chalcedony Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002270 gangliosides Chemical class 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 229940094720 viagra Drugs 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 229910001209 Low-carbon steel Inorganic materials 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241001400472 Omiza Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003129 oil well Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000000580 secretagogue effect Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
나 이 | ㉮ 효능을 확실히 느낀다 | ㉯ 효능을 느낀다 | ㉰ 조금 느낀다 | ㉱ 잘 모르겠다 |
50 ~ 59세 | 2 | 5 | 2 | 1 |
60세 이상 | 1 | 4 | 3 | 2 |
나 이 | ㉮ 효능을 확실히 느낀다 | ㉯ 효능을 느낀다 | ㉰ 조금 느낀다 |
㉱ 잘 모르겠다 |
40 ~ 49세 | 2 |
4 | 2 | 2 |
50세 이상 | 1 |
4 | 3 | 2 |
Claims (12)
- 액상인 고형분 50 ~ 80중량%로서의 홍삼농축액 5 ~ 15중량부, 고형분 3 ~ 10중량%로서의 생녹골추출물 4 ~ 8중량부, 고형분 3 ~ 10중량%로서의 생녹용추출물 0.2 ~ 0.8중량부와 분쇄된 건조상태의 생약재인 당귀 4 ~ 8중량부, 천궁 4 ~ 8중량부, 계피 4 ~ 8중량부, 다시마뿌리 4 ~ 8중량부, 백복령 4 ~ 8중량부, 백복신 4 ~ 8중량부, 오미자 3 ~ 7중량부, 작약 2 ~ 5중량부, 단삼 2 ~ 5중량부, 건율 2 ~ 5중량부, 옥미수 2 ~ 5중량부, 양강 2 ~ 5중량부, 누에 2 ~ 5중량부, 백출 1 ~ 4중량부, 건강 1 ~ 4중량부, 건해삼 1 ~ 4중량부, 대추 1 ~ 2중량부, 맥아 1 ~ 2중량부와 부형제로서 분말인 씨엠씨(CMC) 1 ~ 3중량부를 혼합하여 제환하고 수분 3 ~ 7중량%로 건조하는 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품의 제조방법.
- 제 1항에 있어서, 상기 홍삼농축액은 홍삼을 70 ~ 100℃로 추출하고 진공도 600 ~ 700㎜Hg로 감압하에 온도 40 ~ 80℃에서 고형분 50 ~ 80중량%로 농축한 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품의 제조방법.
- 제 1항에 있어서, 상기 생녹골추출물은 생녹골에 물 5 ~ 15배수를 첨가하여 100℃에서 6 ~ 10시간 추출하고 여과하여 고형분 3 ~ 10중량%로 하는 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품의 제조방법.
- 제 1항 또는 제 3항에 있어서, 상기 생녹골추출물은 전체 생녹골에 대하여 사슴고기가 15 ~ 30중량% 포함된 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품의 제조방법.
- 제 1항에 있어서, 상기 생녹용추출물은 생녹용에 물 3 ~ 10배수를 첨가하여 100℃에서 6 ~ 10시간 추출하고 여과하여 고형분 3 ~ 10중량%로 하는 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품의 제조방법.
- 제 1항에 있어서, 상기 분쇄된 생약재는 건조된 생약재를 80 ~ 120mesh 분쇄한 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품의 제조방법.
- 제 1항에 있어서, 상기 건조한 환은 프락토올리고당으로 코팅하는 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품의 제조방법.
- 액상인 고형분 50 ~ 80중량%로서의 인삼농축액 5 ~ 15중량부, 고형분 3 ~ 10중량%로서의 생녹골추출물 4 ~ 8중량부, 고형분 3 ~ 10중량%로서의 생녹용추출물 0.2 ~ 0.8중량부와 분쇄된 건조상태의 생약재인 당귀 4 ~ 8중량부, 천궁 4 ~ 8중량부, 계피 4 ~ 8중량부, 다시마뿌리 4 ~ 8중량부, 백복령 4 ~ 8중량부, 백복신 4 ~ 8중량부, 오미자 3 ~ 7중량부, 작약 2 ~ 5중량부, 단삼 2 ~ 5중량부, 건율 2 ~ 5중량부, 옥미수 2 ~ 5중량부, 양강 2 ~ 5중량부, 누에 2 ~ 5중량부, 백출 1 ~ 4중량부, 건강 1 ~ 4중량부, 건해삼 1 ~ 4중량부, 대추 1 ~ 2중량부, 맥아 1 ~ 2중량부와 부형제로서 분말인 씨엠씨(CMC) 1 ~ 3중량부를 배합 혼합하여 환 형태로 제조된 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품.
- 제 8항에 있어서, 상기 인삼농축액은 고형분 50 ~ 80중량%, 생녹골추출물은 고형분 3 ~ 10중량%, 생녹용추출물은 고형분 3 ~ 10중량%인 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품.
- 제 8항 또는 제 9항에 있어서, 상기 생녹골추출물은 전체 생녹골에 대하여 사슴고기가 15 ~ 30중량% 함유된 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품.
- 제 8항에 있어서, 상기 환은 프락토올리고당으로 코팅된 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품.
- 제 8항 또는 제 9항에 있어서, 인삼농축액은 홍삼, 백삼, 곡삼, 피부백삼, 태극삼, 미삼 등 통상의 인삼을 원료로 하되 이들 인삼 중 어느 하나 또는 둘 이상을 혼합하여 추출 농축되는 것을 특징으로 하는 생약재를 주재로 한 환제 정력보강식품.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080096215A KR101002774B1 (ko) | 2008-09-30 | 2008-09-30 | 생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080096215A KR101002774B1 (ko) | 2008-09-30 | 2008-09-30 | 생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100036820A KR20100036820A (ko) | 2010-04-08 |
KR101002774B1 true KR101002774B1 (ko) | 2010-12-21 |
Family
ID=42214272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080096215A KR101002774B1 (ko) | 2008-09-30 | 2008-09-30 | 생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101002774B1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103431297A (zh) * | 2013-08-02 | 2013-12-11 | 董松节 | 一种养心安神灵芝粥 |
WO2014178448A1 (ko) * | 2013-04-30 | 2014-11-06 | 주식회사 한국전통의학연구소 | 당귀 추출물과 삼지구엽초 추출물을 포함하는 남성 불임 예방 또는 개선용 조성물 |
KR102091737B1 (ko) | 2018-09-14 | 2020-03-20 | 주식회사 한국인삼공사 | 홍삼환의 제조 방법 |
KR20220000666A (ko) | 2020-06-26 | 2022-01-04 | 제천한약영농조합법인 | 정력개선을 위한 리큐르주의 제조방법 |
KR20230080173A (ko) | 2021-11-29 | 2023-06-07 | 주식회사 한국인삼공사 | 식감 및 관능성이 개선된 홍삼 환의 제조 방법 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103063793A (zh) * | 2013-01-01 | 2013-04-24 | 吉林紫鑫药业股份有限公司 | 锁阳补肾胶囊的含量测定方法 |
KR101870940B1 (ko) * | 2016-04-15 | 2018-06-27 | 한국인스팜(주) | 야관문과 홍삼을 함유한 남성갱년기 증후군 개선용 건강식품조성물 |
-
2008
- 2008-09-30 KR KR1020080096215A patent/KR101002774B1/ko active IP Right Grant
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014178448A1 (ko) * | 2013-04-30 | 2014-11-06 | 주식회사 한국전통의학연구소 | 당귀 추출물과 삼지구엽초 추출물을 포함하는 남성 불임 예방 또는 개선용 조성물 |
CN103431297A (zh) * | 2013-08-02 | 2013-12-11 | 董松节 | 一种养心安神灵芝粥 |
KR102091737B1 (ko) | 2018-09-14 | 2020-03-20 | 주식회사 한국인삼공사 | 홍삼환의 제조 방법 |
KR20220000666A (ko) | 2020-06-26 | 2022-01-04 | 제천한약영농조합법인 | 정력개선을 위한 리큐르주의 제조방법 |
KR20230080173A (ko) | 2021-11-29 | 2023-06-07 | 주식회사 한국인삼공사 | 식감 및 관능성이 개선된 홍삼 환의 제조 방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20100036820A (ko) | 2010-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101002774B1 (ko) | 생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 | |
KR101244302B1 (ko) | 탈모에 효과적인 건강보조식품 및 그 제조방법 | |
CN104288495A (zh) | 一种山药黄精胶囊及其制备方法 | |
CN106509887A (zh) | 一种抗疲劳保健组合物及其制备方法 | |
CN105770420A (zh) | 一种具有抗癌作用的中草药剂及其制备方法 | |
AU2016201968A1 (en) | Sporoderm-broken ganoderma lucidum spore powder, honey & propolis buccal tablet and manufacturing method thereof | |
CN103610077A (zh) | 一种海参胶囊 | |
CN101314024A (zh) | 一种治疗艾滋病的中药胶囊 | |
CN102061247B (zh) | 一种复方参茸杜仲养生酒及其制备方法 | |
CN111467468A (zh) | 一种含人参、蛹虫草、生姜、枸杞子浓缩营养液及其制备方法 | |
CN103610076A (zh) | 一种海参胶囊的制造方法 | |
CN106723048A (zh) | 一种用于缓解疲劳的保健食品及其制备方法 | |
CN102715509A (zh) | 一种排毒养颜保健品 | |
CN106177166A (zh) | 一种具有缓解体力疲劳功能的组合物及其制备方法 | |
CN109453317A (zh) | 一种用于滋补强壮的蒙药及其制备工艺 | |
CN101574509A (zh) | 容颜不老制剂 | |
CN108633997A (zh) | 一种具有抗疲劳功能的保健羊奶粉及其制备方法 | |
CN104258199A (zh) | 一种用于防治羊白肌病的中药组合物及其制备方法 | |
KR101606913B1 (ko) | 강황을 이용한 건강음료 제조방법 | |
CN107233491A (zh) | 一种提高精力抗疲劳的玛咖组合物 | |
CN113456778A (zh) | 一种提升能量的组合物及其制备方法 | |
CN105832787A (zh) | 一种三七西洋参复合制剂及其制备方法与应用 | |
CN111588029A (zh) | 一种黄精膏组合物 | |
CN110584037A (zh) | 一种食品人参膏及其制备方法 | |
CN111228408A (zh) | 一种增强男性性能力的鹿鞭人参牡蛎软胶囊及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131126 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20141118 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150918 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160920 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170919 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180920 Year of fee payment: 9 |